These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 1662924
1. Identification and characterisation in vitro of cells with a non-SCLC cell-like phenotype derived from a continuous SCLC cell line. Khan MZ, Freshney RI, Murray AM, Merry S, Plumb JA, McNicol AM. Anticancer Res; 1991; 11(5):1687-95. PubMed ID: 1662924 [Abstract] [Full Text] [Related]
2. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Gazdar AF, Carney DN, Nau MM, Minna JD. Cancer Res; 1985 Jun; 45(6):2924-30. PubMed ID: 2985258 [Abstract] [Full Text] [Related]
3. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD. Cancer Res; 1985 Jun; 45(6):2913-23. PubMed ID: 2985257 [Abstract] [Full Text] [Related]
4. Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide. Nakajima T, Shimosato Y, Morinaga S, Terasaki T, Tsumuraya M, Yamaguchi K, Ichinose H, Nagatsu T, Kato K, Nakazato Y. Jpn J Clin Oncol; 1986 Sep; 16(3):223-33. PubMed ID: 2430122 [Abstract] [Full Text] [Related]
5. Tumorigenicity, invasion and metastasis of the small cell lung cancer cell line NCI-H69 and two derivative lines MOG-H69V and MOG-H69VZ. Khan MZ, McNicol AM, Freshney RI. Anticancer Res; 1996 Sep; 16(4A):1659-69. PubMed ID: 8712684 [Abstract] [Full Text] [Related]
7. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI. Cancer Res; 1990 Sep 15; 50(18):6068-74. PubMed ID: 2168288 [Abstract] [Full Text] [Related]
8. Characterization of two cell lines with distinct phenotypes established from a patient with small cell lung cancer. Bepler G, Jaques G, Havemann K, Koehler A, Johnson BE, Gazdar AF. Cancer Res; 1987 Apr 01; 47(7):1883-91. PubMed ID: 3028617 [Abstract] [Full Text] [Related]
9. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line. Walker C, Wright-Perkins S. Oncol Res; 1992 Apr 01; 4(10):419-29. PubMed ID: 1337994 [Abstract] [Full Text] [Related]
10. Long-term selective culture of hamster pulmonary endocrine cells. Linnoila RI, Gazdar AF, Funa K, Becker KL. Anat Rec; 1993 May 01; 236(1):231-40. PubMed ID: 8389531 [Abstract] [Full Text] [Related]
11. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line. Watanabe H, Takahashi T, Ueda R, Utsumi KR, Sato T, Ariyoshi Y, Ota K, Obata Y, Takahashi T. Cancer Res; 1988 May 01; 48(9):2544-9. PubMed ID: 2833350 [Abstract] [Full Text] [Related]
12. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines. Bepler G, Jaques G, Koehler A, Gropp C, Havemann K. J Cancer Res Clin Oncol; 1987 May 01; 113(3):253-9. PubMed ID: 2438285 [Abstract] [Full Text] [Related]
13. [Pathology and biology of small cell lung cancer]. Shimosato Y. Gan To Kagaku Ryoho; 1988 Apr 01; 15(4 Pt 2-1):952-8. PubMed ID: 2839114 [Abstract] [Full Text] [Related]
14. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Bepler G, Bading H, Heimann B, Kiefer P, Havemann K, Moelling K. Oncogene; 1989 Jan 01; 4(1):45-50. PubMed ID: 2536917 [Abstract] [Full Text] [Related]
15. Lack of expression of P-glycoprotein in 7 small cell lung cancer cell lines established both from untreated and from treated patients. Milroy R, Plumb JA, Batstone P, Maclay A, Wishart GC, Hay FG, Candlish W, Adamson R, Khan MZ, Banham S. Anticancer Res; 1992 Jan 01; 12(1):193-200. PubMed ID: 1348921 [Abstract] [Full Text] [Related]
16. Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p. Graziano SL, Cowan BY, Carney DN, Bryke CR, Mitter NS, Johnson BE, Mark GE, Planas AT, Catino JJ, Comis RL. Cancer Res; 1987 Apr 15; 47(8):2148-55. PubMed ID: 3030544 [Abstract] [Full Text] [Related]
17. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE. Cancer Res; 1996 Feb 15; 56(4):831-9. PubMed ID: 8631021 [Abstract] [Full Text] [Related]
18. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts. Arvelo F, Poupon MF, Le Chevalier T. Anticancer Res; 1994 Feb 15; 14(5A):1893-901. PubMed ID: 7847823 [Abstract] [Full Text] [Related]
19. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines. Kado-Fong H, Malfroy B. J Cell Biochem; 1989 Aug 15; 40(4):431-7. PubMed ID: 2550492 [Abstract] [Full Text] [Related]
20. Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. de Leij L, Postmus PE, Buys CH, Elema JD, Ramaekers F, Poppema S, Brouwer M, van der Veen AY, Mesander G, The TH. Cancer Res; 1985 Dec 15; 45(12 Pt 1):6024-33. PubMed ID: 2998591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]